Evidence map›Paper›PMID 42510844›Full record

ArticleGenes2026

Integrative Genomic and Transcriptomic Analysis Identifies BAX as a Prognostic Marker of Disease Progression in Prostate Cancer.

You-Cheng Shih, Chi-Fen Chang, Chao-Yuan Huang, Chia-Cheng Yu, Victor C Lin, Te-Ling Lu, Shu-Pin Huang, Bo-Ying Bao

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

You-Cheng ShihDepartment of Pharmacy, China Medical University, Taichung 406, Taiwan.
Chi-Fen ChangDepartment of Anatomy, School of Medicine, China Medical University, Taichung 406, Taiwan.
Chao-Yuan HuangDepartment of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Chia-Cheng YuDivision of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.ORCID 0000-0002-2620-1914
Victor C LinDepartment of Urology, E-Da Hospital, Kaohsiung 824, Taiwan.
Te-Ling LuDepartment of Pharmacy, China Medical University, Taichung 406, Taiwan.ORCID 0000-0003-1408-6004
Shu-Pin HuangGraduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Bo-Ying BaoDepartment of Pharmacy, China Medical University, Taichung 406, Taiwan.ORCID 0000-0001-5510-6513

Funding

China Medical University CMU111-MF-09, CMU112-MF-10, CMU113-TC-04, CMU113-MF-11, CMU114-S-50, and CMU114-MF-80Kaohsiung Medical University KMUH112-2R59, KMUH113-3R52, KMUH114-4M54, and KMUH114-4R59National Science and Technology Council 110-2314-B-002-113, 111-2314-B-002-240-MY3, 111-2320-B-039-021-MY3, 111-2218-E-037-001, 112-2218-E-037-001, 113-2218-E-037-001, 112-2314-B-037-127, 113-2314-B-037-016, and 114-2320-B-039-024-MY3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bcl-2-Associated X ProteinBiomarkers, TumorProstatic NeoplasmsAgedDisease ProgressionEndoplasmic Reticulum StressGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPolymorphism, Single NucleotidePrognosisTranscriptomeBAX protein, humanbcl-2-Associated X ProteinBiomarkers, Tumorandrogen deprivation therapyBAXbiomarkerendoplasmic reticulum stressprostate cancer

Identifiers

PMID42510844
PMCPMC13409293

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.